首页> 美国卫生研究院文献>The American Journal of Tropical Medicine and Hygiene >Antileishmania Immunological Tests for Asymptomatic Subjects Living in a Visceral Leishmaniasis-Endemic Area in Brazil
【2h】

Antileishmania Immunological Tests for Asymptomatic Subjects Living in a Visceral Leishmaniasis-Endemic Area in Brazil

机译:针对生活在巴西内脏利什曼病流行地区的无症状受试者的抗利什曼病免疫学测试

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to evaluate the behavior of different tests used for the diagnosis of visceral leishmaniasis (VL) in asymptomatic subjects living in an endemic area. No gold standard is available for the diagnosis of asymptomatic infection with Leishmania. In continuation of a previous study, 1,017 subjects living in a VL-endemic area were clinically reevaluated. Of these, 576 had at least one positive serological test in a first assessment. About 3 years after the first evaluation, none of the subjects had progressed to clinical VL. Among this group, 246 subjects were selected, and five serological tests (enzyme-linked immunosorbent assay p [ELISAp], ELISArK39, ELISArK26, indirect immunofluorescence test [IIFT] using L. amazonensis promastigote antigen, and an immunochromatographic test using rK39 antigen [TRALd]) and the Montenegro skin test (MST) were repeated. There was a significant increase in the number of subjects who tested positive in the MST, IIFT, ELISAp, and ELISArK39 in the second evaluation. For all tests, there were subjects who tested positive in the first evaluation and negative in the second evaluation. A positive result in the serological tests and MST in subjects from the endemic area studied did not indicate a risk of progression to VL and may only be temporary.
机译:这项研究的目的是评估生活在流行地区无症状受试者中用于诊断内脏利什曼病(VL)的不同测试的行为。没有黄金标准可用于诊断利什曼原虫无症状感染。在先前研究的继续中,对生活在VL流行地区的1,017名受试者进行了临床重新评估。其中,576名患者在首次评估中至少接受了一次阳性血清学检查。第一次评估后约3年,所有受试者均未进展为临床VL。在这一组中,选择了246名受试者,并进行了五项血清学检测(酶联免疫吸附测定p [ELISAp],ELISArK39,ELISArK26,使用亚马逊乳杆菌前鞭毛抗原进行的间接免疫荧光测试[IIFT]以及使用rK39抗原[TRALd]的免疫色谱测试])和黑山皮肤测试(MST)进行了重复。在第二次评估中,在MST,IIFT,ELISAp和ELISArK39中检测为阳性的受试者数量显着增加。对于所有测试,有些受试者在第一次评估中测试为阳性,而在第二次评估中测试为阴性。在来自所研究的流行地区的受试者中,血清学检查和MST的阳性结果并不表明有发展为VL的风险,可能只是暂时的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号